On May 21, 2026, the news about the “AI leader” finally moving toward the public market was suddenly accelerated: multiple media outlets simultaneously cited insiders saying that OpenAI is closely collaborating with Goldman Sachs and Morgan Stanley to prepare for an IPO in the U.S. market, and plans to submit a confidential filing for the IPO secretly — the earliest possible date was pointed to this Friday, May 22; more aggressive claims suggested that if everything goes smoothly, the company is expected to initiate the listing process by September 2026. The timeline has been pushed forward layer by layer, and Wall Street has begun to imagine the day’s bell ringing as “one of the most highly anticipated AI IPOs,” while the parties involved remain silent: as of now, OpenAI has not publicly responded to any specific time, scale, or location, and all rhythms remain within the realm of “insiders” and “market expectations.” The global capital and tech worlds have already focused on a prospectus that has not yet appeared, while the formal documents are locked away in the confidential submission process. Between expectation and uncertainty, the company's next steps have been pushed to a critical moment of highly asymmetric information.

Confidential Filing: Acceleration or Concealment

The so-called confidential filing means that companies can submit IPO registration documents to regulatory authorities and maintain a “one-line contact” with regulators for an extended period. The documents can be modified and supplemented multiple times in a non-public state, only to be thrown into the market in the form of a public version of the prospectus just before the roadshow or formal issuance. The impact on the rhythm is evident: if the confidential filing is completed as early as late May, internal reviews and Q&As can quietly progress, while the outside world only sees a “quiet period” and cannot glimpse the turbulent changes in terms and adjustments; regarding information disclosure, it pushes back the exposure time of the most sensitive financial data, business breakdowns, and commercial terms by a substantial margin.

Applying this choice to OpenAI, it seems almost logically written: as a highly sensitive AI technology and commercialization target, it must address in its prospectus issues including model R&D costs, computing power procurement, and revenue structure, as well as external questions about safety, risk control, and data sources. Confidential filing gives it the opportunity to refine these disclosure boundaries in a closed environment of regulators and investment banks before the spotlight turns on, allowing for greater flexibility to hedge against regulatory feedback, market fluctuations, and competitors’ “alignment.” However, controversy arises — when a company seen as a “weather vane” of the AI era chooses to remain silent about early crucial documents, the game of transparency versus regulation is pushed to the forefront: regulatory agencies are generally more cautious about information disclosure in large tech IPOs, and the greater the market expectation, the more likely every number and paragraph will become a touchstone for testing corporate governance and regulatory scales when it truly goes public.

Goldman Sachs and Morgan Stanley's Endorsement Signal

While the details of the prospectus remain locked in the confidential filing process, one of the only “hard clues” that the market can grasp is the names of the investment banks standing at the issuance podium. Multiple Chinese tech and crypto media outlets (such as Golden Finance, Odaily Planet Daily, BlockBeats, etc.) reported simultaneously during the same timeframe that Goldman Sachs and Morgan Stanley are preparing for the IPO in collaboration with OpenAI. These two investment banks, which frequently appear in global tech capital stories, being part of the same underwriting line-up itself is interpreted as a direct signal of scale and attention — this combination usually only appears in massive, highly narrative-focused internet or cloud computing leaders.

Historically, Goldman Sachs and Morgan Stanley often handle tech IPO projects with large single financing amounts and many participating institutions; they are not only familiar with the narrative structure of high-growth tech companies but are also regarded by institutional investors as professional intermediaries “capable of selling complex stories.” Therefore, when the market sees these two jointly betting on OpenAI, expectations naturally shift toward a larger scale and more intense subscriptions: the primary market will preemptively view this combination as an endorsement of the success rate of issuance and funding organization ability during valuation negotiations; the secondary market will consider this potential IPO as a new anchor for the AI sector, pre-trading expectations on relevant AI concepts and tech stocks even before the formal prospectus becomes public, pushing the entire sector's valuation imagination into a higher, more fragile range.

Market Rumors Fly: Earliest Listing in September

After Goldman Sachs and Morgan Stanley were mentioned, the timeline became the most sensitive part of the market. Several Chinese media outlets wrote similar phrases around May 21 — OpenAI plans to submit a confidential filing to regulatory authorities “in the coming days or weeks,” and some sources compressed the timeline further to “as early as this Friday,” clearly marked as “market news.” Almost in the same wave of reports, some “insiders” launched a second layer of expectations: the company internally regards “the earliest listing to start in September 2026” as a goal, but emphasizes that it is just a goal and a possibility. From “to submit within a few days or weeks” to “earliest listing in September” represents a chain of extended expectations rather than a schedule written in stone in the prospectus; more critically, as of May 21, OpenAI has not publicly confirmed any timeline, each cell of this timeline is labeled “variable.”

For participants in the secondary market, this timeline, with its vague boundaries, has itself become a tradable asset. During the earliest rumor phase, funds often preemptively position themselves in AI concepts and tech stocks, imagining the “submission notification for the coming days or weeks” as an emotional catalyst that could land anytime; once more snippets about the confidential filing or regulatory progress emerge, the imagination automatically pushes toward the window of “roadshows and listings around September,” and the valuation of industry chain targets will also be preemptively discounted for a grandeur listing that has not yet been officially announced. The issue is that as long as all timelines stay within the realm of “insiders revealed,” this expectation-driven layout is destined to carry high-leverage emotional attributes: if progress goes smoothly, it will be narrated as the annual main story of the AI sector; if the timeline is forced to delay or quietly diminish, it could also quickly backlash against the entire sector, turning the collective imagination of “earliest listing in September” into a stress test of amplified volatility.

Privacy and Regulation: The Controversy of Confidential Filing

For an IPO seen as “the battle for the pricing power of the AI leader,” OpenAI's choice of confidential filing inherently heightens the tension between regulation and investor protection. The confidential filing pathway means that early application documents only circulate between regulatory bodies and the company, with outsiders unable to know even the most basic valuation ranges, issuance scale, or listing locations; the question of “whether it will immediately aim for a trillion-dollar valuation” currently belongs purely to market speculation without any official statement or supporting document. In the absence of an official timeline and announcements regarding structure and valuation, insiders’ snippets become the primary material for emotional pricing, and this phase replaces the prospectus with rumors, naturally amplifying information asymmetry: large institutions can at least repeatedly gauge expectations through channels, while ordinary investors can only guess what kind of financial and governance prospects they are actually buying into in the whirlpool of public opinion.

This round of information vacuum period also lays suspense for subsequent regulatory Q&As and the public unveiling of the prospectus. As a subject that simultaneously plays the dual roles of research institution and commercial company, OpenAI's most sensitive questions have never been about “whether to tell a story,” but rather how it coherently aligns its governance structure and profit model: who makes decisions at key points, how commercial goals are embedded in the original mission, and how future profits and control are delineated among different stakeholders. By the time the confidential filing phase concludes and formal registration documents become public, the market's most pragmatic concerns will focus on a few key issues — whether income and costs can support the currently imagined high valuation, whether governance arrangements are sufficient to constrain power and incentive mismatches, and whether these answers justify paying a premium for what is dubbed “the most highly watched IPO in AI history.”

Between Expectation and Uncertainty

Returning to the present, this narrative surrounding OpenAI's IPO has only a few relatively clear points: the company is indeed preparing for an IPO, the path is locked in as a confidential filing to regulatory bodies, and Goldman Sachs and Morgan Stanley are already involved; however, all concrete timelines — including “earliest submission on May 22” and “earliest listing to start in September” — as of May 21, 2026, are merely the wording of media and insiders, without official confirmation and potentially subject to rewriting by market and regulatory environments. At this stage where sentiment has already outrun the story, investors must take into account both the official ongoing silence and the high uncertainty of the time points in their pricing: delays in nodes and a slowing rhythm are not uncommon, and what truly deserves close attention is the regulatory feedback on structural and disclosure requirements, when the prospectus will be made public and the commercial and governance details revealed within it, and whether this IPO will ultimately be able to stabilize in both the primary and secondary markets, becoming a new anchor point for valuation and sentiment in the AI sector rather than just another peak of short-term narrative.

Join our community, let’s discuss and become stronger together!
Official Telegram community: https://t.me/aicoincn
AiCoin Chinese Twitter: https://x.com/AiCoinzh
OKX Benefits Group: https://aicoin.com/link/chat?cid=l61eM4owQ
Binance Benefits Group: https://aicoin.com/link/chat?cid=ynr7d1P6Z

免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到support@aicoin.com，本平台相关工作人员将会进行核查。